The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Molecular and Cellular Evidence for an Oligodendrocyte Abnormality in Schizophrenia
Abstract
Our previous analyses in postmortem prefrontal cortex samples from a well-characterized cohort of severely affected schizophrenics and in matched controls demonstrated decreased expression of myelin and oligodendrocyte-related genes in the disease state. This decreased expression, now replicated in independent studies, suggests that there is a disruption of oligodendrocyte function and/or a loss of oligodendrocytes in schizophrenia. In the current report, we review expression studies in schizophrenia and present data demonstrating consistently fewer oligodendrocytes in schizophrenics compared to controls. The decrease in density reached 22% (p < 0.01) in layer III of area 9 and 20% (p < 0.02) in the white matter of the superior frontal gyrus. These data, when taken together with expression studies carried out by us and by other groups, and by imaging and other microscopic studies, point to a major involvement of oligodendrocyte abnormalities in schizophrenia. Therapies modulating oligodendrocyte survival and differentiation may therefore be beneficial in schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in particular, in schizophrenia a reduction of oligodendrocytes has also been reported in the frontal cortex (Hof et al, 2002(Hof et al, , 2003)).”
From Neurocircuitry of Mood Disorders (2010) · cites this paper as Hof et al, 2002
In the citing paper
“Finally, decreases in oligodendrocyte density are probably not specific to mood disorders; in particular, in schizophrenia a reduction of oligodendrocytes has also been reported in the frontal cortex (Hof et al, 2002(Hof et al, , 2003)).”
From Neurocircuitry of Mood Disorders (2010) · cites this paper as Hof et al, 2002
Citations
Cites
West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994
Neuregulin 1 and Susceptibility to Schizophrenia
Stefánsson, H., Pétursson, H., Sigurðsson, E., Steinthórsdóttir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,671
Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192
Self-citationMirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., & Levitt, P. (2000) · Neuron · doi:10.1016/s0896-6273(00)00085-4 · Cited by 882
Functional and Anatomical Aspects of Prefrontal Pathology in Schizophrenia
Goldman-Rakic, P. S., & Selemon, L. D. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.3.437 · Cited by 668
Electron microscopy of oligodendroglia in severe mental illness
Uranova, N., Orlovskaya, D., Vikhreva, O., Zimina, I., Kolomeets, N., Vostrikov, V., & Rachmanova, V. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00528-7 · Cited by 495
Myelination of Cortical-hippocampal Relays During Late Adolescence
Benes, F. M. (1989) · Schizophrenia Bulletin · doi:10.1093/schbul/15.4.585 · Cited by 448
Compromised White Matter Tract Integrity in Schizophrenia Inferred From Diffusion Tensor Imaging
Lim, K. O., Hedehus, M., Moseley, M. E., de Crespigny, A. J., Sullivan, E. V., & Pfefferbaum, A. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.4.367 · Cited by 447
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., & Levitt, P. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000866 · Cited by 446
Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia
Middleton, F. A., Mirnics, K., Pierri, J. N., Lewis, D. A., & Levitt, P. R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02718.2002 · Cited by 425
Flagged first, then by citations
Research works printed but not linked: 1
- Copland, C., Dracheva, S., Davis, K. L., and Haroutunian, V. 2002. mRNA expression of three isoforms of myelin associated glycoprotein (MAG) in patients with schizophrenia. Soc. Neurosci. Abs., in press.
Cited by
Sorted by citations
Items 101–199 of 199
Tishler, T. A., Bartzokis, G., Lu, P. H., Raven, E. P., Khanoyan, M., Kirkpatrick, C. J., Pyle, M., Villablanca, J. P., Altshuler, L. L., Mintz, J., et al. (2017) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.03.007 · Cited by 36
Tunc‐Skarka, N., Weber‐Fahr, W., Hoerst, M., Meyer‐Lindenberg, A., Zink, M., & Ende, G. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.061 · Cited by 34
Kreczmański, P., Heinsen, H., Mantua, V., Woltersdorf, F., Masson, T., Ulfig, N., Schmidt‐Kastner, R., Korr, H., Steinbusch, H. W. M., Hof, P. R., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0482-7 · Cited by 33
Self-citationReduced Intracortical Myelination in Schizophrenia
Bartzokis, G., & Altshuler, L. L. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1229-a · Cited by 32
Kaiser, S., Foltz, L., George, C., Kirkwood, S. C., Bemis, K. G., Lin, X., Gelbert, L. M., & Nisenbaum, L. K. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.011 · Cited by 31
Kimoto, S., Okuda, A., Toritsuka, M., Yamauchi, T., Makinodan, M., Okuda, H., Tatsumi, K., Nakamura, Y., Wanaka, A., & Kishimoto, T. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.07.011 · Cited by 29
Jeanblanc, J., Peterschmitt, Y., Hoeltzel, A., & Louilot, A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.022 · Cited by 29
The role of white matter for the pathophysiology of schizophrenia
Brambilla, P., & Tansella, M. (2007) · International Review of Psychiatry · doi:10.1080/09540260701500975 · Cited by 28
Bernstein, H., Smalla, K., Dürrschmidt, D., Keilhoff, G., Dobrowolny, H., Steiner, J. H., Schmitt, A., Kreutz, M. R., & Bogerts, B. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8185-y · Cited by 28
Komatsu, H., Takeuchi, H., Kikuchi, Y., Ono, C., Yu, Z., Iizuka, K., Takano, Y., Kakuto, Y., Funakoshi, S., Ono, T., et al. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa049 · Cited by 27
Progenitor cell-based treatment of glial disease
Goldman, S. A. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2017.02.010 · Cited by 25
DNA Microarray Analysis of Postmortem Brain Tissue
Mirnics, K., Levitt, P. R., & Lewis, D. A. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)60006-7 · Cited by 26
Aydın, K., Ucok, A., & Cakir, S. (2007) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0691 · Cited by 25
Kito, S., Jung, J., Kobayashi, T., & Koga, Y. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2008.12.012 · Cited by 23
Is Brain Banking of Psychiatric Cases Valuable for Neurobiological Research?
Schmitt, A., Parlapani, E., Bauer, M., Heinsen, H., & Falkai, P. (2008) · Clinics · doi:10.1590/s1807-59322008000200015 · Cited by 22
Palaniyappan, L. K., Al‐Radaideh, A., Mougin, O. E., Das, T., Gowland, P. A., & Liddle, P. F. (2018) · Psychological Medicine · doi:10.1017/s0033291718002647 · Cited by 22
Brisch, R., Bernstein, H., Krell, D., Dobrowolny, H., Bielau, H., Steiner, J. H., Gos, T., Funke, S., Stauch, R., Knüppel, S., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.02.039 · Cited by 22
Polymorphisms of Transferrin gene are associated with schizophrenia in Chinese Han population
Qu, M., Yue, W., Tang, F., Wang, L., Han, Y., & Zhang, D. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.10.005 · Cited by 22
Drakesmith, M., Dutt, A., Fonville, L., Zammit, S., Reichenberg, A., Evans, J., McGuire, P. K., Lewis, G., Jones, D. K., & David, A. S. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.09.002 · Cited by 21
Neuroanatomical changes in the adult rat brain after neonatal lesion of the medial prefrontal cortex
Klein, S., Koch, M., & Schwabe, K. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.09.015 · Cited by 21
Hasan, A., Bergener, T., Nitsche, M. A., Strube, W., Bunse, T., Falkai, P., & Wobrock, T. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00121 · Cited by 21
Fear Deficits in HypomyelinatedTpppKnock-Out Mice
Nguyen, H., Meservey, L. M., Ishiko, N., Zhou, M., Huang, T., & Fu, M. (2020) · eNeuro · doi:10.1523/eneuro.0170-20.2020 · Cited by 20
Bernstein, H., Jauch, E., Dobrowolny, H., Mawrin, C., Steiner, J., & Bogerts, B. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0640-y · Cited by 18
Pathophysiology of Schizophrenia
Falkai, P., Schmitt, A., & Cannon, T. D. (2011) · Wiley eBooks · doi:10.1002/9780470978672.ch2 · Cited by 18
Chwa, W. J., Tishler, T. A., Raymond, C., Tran, C., Anwar, F., Villablanca, J. P., Ventura, J., Subotnik, K. L., Nuechterlein, K. H., & Ellingson, B. M. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.03.073 · Cited by 18
Olanzapine increases cell mitotic activity and oligodendrocyte-lineage cells in the hypothalamus
Yamauchi, T., Tatsumi, K., Makinodan, M., Kimoto, S., Toritsuka, M., Okuda, H., Kishimoto, T., & Wanaka, A. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.07.003 · Cited by 18
Usui, H., Takahashi, N., Saito, S., Ishihara, R., Aoyama, N., Ikeda, M., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., et al. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.07.019 · Cited by 18
Axonal myelin increase in the callosal genu in depression but not schizophrenia
Williams, M. R., Sharma, P., Fung, K. L., Pearce, R. K. B., Hirsch, S. R., & Maier, M. (2015) · Psychological Medicine · doi:10.1017/s0033291715000136 · Cited by 17
Che, R., Tang, W., Zhang, J., Wei, Z., Zhang, Z., Huang, K., Zhao, X., Gao, J., Zhou, G., Huang, P., et al. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-31 · Cited by 17
Kolomeets, N. S., Vm, V., & Uranova, N. A. (2013) · The European Journal of Psychiatry · doi:10.4321/s0213-61632013000400003 · Cited by 17
Leroux, E., Delcroix, N., Alary, M., Razafimandimby, A., Brazo, P., Delamillieure, P., & Dollfus, S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.016 · Cited by 18
Contributions of Glutamate and GABA Systems to the Neurobiology and Treatment of Schizophrenia
Krystal, J. H., & Moghaddam, B. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch21 · Cited by 17
Morita, S., Tatsumi, K., Makinodan, M., Okuda, H., Kishimoto, T., & Wanaka, A. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1190-1 · Cited by 16
Harich, S., Kinfe, T. M., Koch, M., & Schwabe, K. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.017 · Cited by 16
Recombinant human IGF-1 for patients with schizophrenia
Khalil, R. B. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.06.001 · Cited by 14
Zhang, Z., & Chen, G. (2020) · The Journal of Comparative Neurology · doi:10.1002/cne.24921 · Cited by 13
Elevated levels of Insulin-like Growth Factor-1 (IGF-1) in drug-naïve patients with psychosis
Petrikis, P., Boumba, V. A., Tzallas, A. T., Voulgari, P. V., Archimandriti, D. T., Skapinakis, P., & Mavreas, V. G. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.09.053 · Cited by 15
Chen, X., Huang, N., Namaka, M., & Xiao, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00451 · Cited by 13
White matter volume change and its correlation with symptom severity in patients with schizophrenia
Kim, G.-W., & Jeong, G. (2015) · Neuroreport · doi:10.1097/wnr.0000000000000471 · Cited by 13
Narita, H., Tha, K. K., Hashimoto, N., Hamaguchi, H., Nakagawa, S., Shirato, H., & Kusumi, I. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.07.011 · Cited by 12
The neurobiology of transition to psychosis: clearing the cache
Palaniyappan, L. K., Das, T., & Dempster, K. (2017) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170137 · Cited by 12
Schoonover, K. E., Farmer, C. B., Morgan, C. J., Sinha, V., Odom, L. B., & Roberts, R. C. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.12.016 · Cited by 10
Insights into myelin dysfunction in schizophrenia and bipolar disorder
Valdés‐Tovar, M., Rodríguez‐Ramírez, A. M., Rodríguez-Cárdenas, L., Sotelo-Ramírez, C. E., Camarena, B., Sanabrais‐Jiménez, M. A., Solís‐Chagoyán, H., Argueta, J., & López-Riquelme, G. O. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i2.268 · Cited by 11
de Sousa, T. R., Correia, D. T., & Novais, F. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210902164235 · Cited by 10
Role of Redox Dysregulation in White Matter Anomalies Associated with Schizophrenia
Monin, A., Fournier, M., Baumann, P., Cuénod, M., & Kim, Q. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00028-6 · Cited by 10
Hossain, M. I., Horie, M., & Takebayashi, H. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2342-5 · Cited by 10
Myelination and Brain Electrophysiology in Healthy and Schizophrenic Individuals
Bartzokis, G. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300180 · Cited by 10
Psychosis and depression - a neurobiological view.
Pregelj, P. (2009) · PubMed · Cited by 9
Lim, K. O. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.995 · Cited by 9
Glial evolution as a determinant of human behavior and its disorders
Goldman, S. A. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14372 · Cited by 9
Hanson, K. L., Avino, T. A., Taylor, S. L., Murray, K. D., & Schumann, C. M. (2025) · Molecular Autism · doi:10.1186/s13229-025-00684-y · Cited by 9
Progressive brain changes in schizophrenia: a 1-year follow-up study of diffusion tensor imaging
Ota, M., Obu, S., Sato, N., Mizukami, K., & Asada, T. (2009) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2009.00422.x · Cited by 7
Interactions between knockout of schizophrenia risk factor Dysbindin-1 and copper metabolism in mice
Schoonover, K. E., McMeekin, L. J., Farmer, C. B., Varghese, N. E., Queern, S. L., Lapi, S. E., Cowell, R. M., & Roberts, R. C. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.07.024 · Cited by 5
Psychiatry's Remarkable Journey: The Past 40 Years
Pardes, H. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.6.896 · Cited by 6
Synaptic Vesicle Associated Proteins and Schizophrenia
Kao, H., & Porton, B. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_7 · Cited by 6
John, J. P., Thirunavukkarasu, P., Halahalli, H. N., Purushottam, M., & Jain, S. (2015) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2014.11.003 · Cited by 5
Protein Succinylation and Malonylation as Potential Biomarkers in Schizophrenia
Smith, B. J., Brandão‐Teles, C., Zuccoli, G. S., Reis‐de‐Oliveira, G., Fioramonte, M., Saia-Cereda, V. M., & Martins‐de‐Souza, D. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091408 · Cited by 5
Funktionell-neuroanatomische und neuropathologische Grundlagen psychischer Erkrankungen
Bogerts, B. (2007) · Springer eBooks · doi:10.1007/978-3-540-33129-2_5 · Cited by 5
Estudos transcriptômicos no contexto da conectividade perturbada em esquizofrenia
Schmitt, A., Reich‐Erkelenz, D., Gebicke‐Haerter, P. J., & Falkai, P. (2012) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832012005000001 · Cited by 4
The Neuropathology of Schizophrenia: Central Role for the Hippocampus?
Falkai, P., Parlapani, E., Gruber, O., & Schmitt, A. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0913-8_7 · Cited by 4
Blood and Brain Gene Expression in Major Psychiatric Disorders: A Search for Biomarkers
Chana, G., Glatt, S. J., Everall, I., & Tsuang, M. T. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_1 · Cited by 4
Neuregulin 1 and Schizophrenia
Chen, Y.-J. J., Role, L. W., & Talmage, D. A. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_6 · Cited by 3
The Neuropathology of White Matter in Schizophrenia
Uranova, N. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-68308-5_11 · Cited by 2
Bedeutung der Frontallappen für die Pathophysiologie schizophrener Erkrankungen
Bogertsc, B. (2005) · Springer eBooks · doi:10.1007/3-540-26841-3_10 · Cited by 2
Gene Expression Changes and Potential Impact of Endophenotypes in Major Psychiatric Disorders
Chana, G., Kwok, J., Glatt, S. J., Everall, I., & Tsuang, M. T. (2009) · Springer eBooks · doi:10.1007/978-90-481-2298-1_3 · Cited by 2
Kolomeets, N. S., & Уранова, Н. А. (2015) · Psikhiatriya · doi:10.30629/2618-6667-2015-67-52-57 · Cited by 2
Louie, A. Y., Rund, L. A., Komiyama‐Kasai, K. A., Weisenberger, K. E., Stanke, K. L., Larsen, R. J., Leyshon, B. J., Kuchan, M. J., Das, T., & Steelman, A. J. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25243 · Cited by 1
Yamamoto, U., Kobayashi, T., Kito, S., & Koga, Y. (2010) · IEEJ Transactions on Electronics Information and Systems · doi:10.1541/ieejeiss.130.799 · Cited by 1
The neurobiology of schizophrenia
Harrison, P. J. (2012) · doi:10.1093/med/9780199696758.003.0077 · Cited by 2
Funktionell-neuroanatomische und neuropathologische Grundlagen psychischer Erkrankungen
Bogerts, B., & Walter, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_6 · Cited by 1
Lipogenic effects of antipsychotic drugs in cultured cells and in rat
Fernø, J. (2007) · NORA - Norwegian Open Research Archives
Glial loss in mood disorders and schizophrenia
Price, J. L. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)31047-1
Neurobiologische Grundlagen der Schizophrenie
Gruber, O., Falkai, P., & Schmitt, A. (2010) · Nervenheilkunde · doi:10.1055/s-0038-1628763
Proteomic Characterization of the Brain and Cerebrospinal Fluid of Schizophrenia Patients
Café-Mendes, C. C., Gattaz, W. F., Schmitt, A., Britto, L. R. G., & Martins‐de‐Souza, D. (2014) · Advances in biological psychiatry · doi:10.1159/000358021
Neurobiologie der Schizophrenien
Bogerts, B., & Steiner, J. H. (2009) · Psychiatrie und Psychotherapie up2date · doi:10.1055/s-0029-1220380
Liao, H., & Mani, D. S. (2011) · Neuroscience & Medicine · doi:10.4236/nm.2011.22014
Castensson, A. (2003) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Schmitt, A., Wobrock, T., Gruber, O., & Falkai, P. (2010) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Aydın, K., Üçok, A., & Çakır, S. (2007)
Studies of the global gene expression changes in alcoholic human brain and blood
Liu, J. (2005) · Texas ScholarWorks (Texas Digital Library)
Machielsen, M. W. J. (2014) · UvA-DARE (University of Amsterdam)
Microarray Analysis of Lipid Metabolism in Drug Abuse, Neurological and Psychiatric Disorders
Lehrmann, E., Chen, J., Lee, C., Freed, W. J., & Becker, K. G. (2004) · CRC Press eBooks · doi:10.1201/9781420030921.ch9
Патология олигодендроглии и когнитивные расстройства при шизофрении
Уранова, Н. А. (2017) · Psikhiatriya · doi:10.30629/2618-6667-2017-76-77-88
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14290-0
Williams, M. R. (2021) · Springer eBooks · doi:10.1007/978-3-030-68308-5_4
Steiner, J. H., & Bogerts, B. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_30
Priller, J. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199794591.003.0071
Paola, V. D., & Khan, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727821479.793555736
Impacts of hnRNP A1 Splicing Inhibition on the Brain Remyelination Proteome
Brandão‐Teles, C., Carregari, V. C., Reis‐de‐Oliveira, G., Smith, B. J., Chaves, Y. C., Santos, A. V. S., Pinheiro, E. M. D. C., Oliveira, C. C., Vieira, A. S., Crunfli, F., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16304
Role of Glial Cells in Neurodegenerative Diseases and Metals-Induced Neurotoxicity
Pajarillo, E. A. B., Nyarko‐Danquah, I., Digman, A., Kim, S., Ajayi, I., Aschner, M., & Lee, E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00227-8
Changes of fractional anisotropy of the cerebral white matter in first-episode schizophrenia
Slezák, O., Žižka, J., Škoch, A., Bayer, D., Španiel, F., Tintěra, J., Jandura, J., & Eliáš, P. (2018) · Česká radiologie · doi:10.55095/cesradiol2018/037
Pavan, T., Wang, Q., Alemán‐Gómez, Y., Jenni, R., Cleusix, M., Alameda, L., Kim, Q., Conus, P., Hagmann, P., Steullet, P., et al. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04072-9 · Cited by 1
Neuregulin-erbB Signaling and the Pathogenesis of Schizophrenia
Roy, C., & Corfas, G. (2007) · Springer eBooks · doi:10.1007/978-0-387-74351-6_4
Developing a rodent model for antipsychotic-induced metabolic adverse effects
Skrede, S. (2012) · NORA - Norwegian Open Research Archives
Unraveling myelin biogenesis: The hidden role in neuropsychiatric disorders
Valdez, K. G., Murambadoro, A. K., Punch, K. D., Martin, B. C., Mourao, N., Szobody, M. W., Gullapalli, S., Sayers, T., Baldado, L., Rodriguez, I. N., et al. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.10.029
Gawłowska-Sawosz, M., & Rabe‐Jabłońska, J. (2007) · Psychiatria i Psychologia Kliniczna
Metadata
- Authors
- Hof, P. R., Haroutunian, V., Copland, C., Davis, K. L., & Buxbaum, J. D.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Buxbaum, Joseph D.
- Venue
- Neurochemical Research
- Published
- 2002-10
- Volume
- 27
- Issue
- 10
- Pages
- 1193-1200
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W132008894
- Cited by
- 199
- References
- 24
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 10 · 2016: 5 · 2015: 12 · 2014: 10 · 2013: 6 · 2012: 13
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01mh045212-05)
- National Institute of Mental Health (MH 45212)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, oligodendrocytes, myelin, oligodendrocyte loss, prefrontal cortex, gene expression, white matter, superior frontal gyrus, oligodendrocyte differentiation, oligodendrocyte survival
- MeSH terms
- Aged, Aged, 80 and over, Brain, Cell Count, Female, Humans, Male, Oligodendroglia, Reference Values, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review